Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenic effects of endotoxin

J B Zivot1, W D Hoffman

  • 1Cleveland Clinic Foundation, Department of General Anesthesiology, OH 44195, USA.

New Horizons (Baltimore, Md.)
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing doses of pentoxifylline as a continuous infusion in canine septic shock.

The Journal of pharmacology and experimental therapeutics·1998
Same author

Emphysematous gastritis.

Surgery·1998
Same author

Noninvasive cardiac output monitoring.

Critical care medicine·1997
Same author

Serial measures of total body oxygen consumption in an awake canine model of septic shock.

American journal of respiratory and critical care medicine·1996
Same author

Nasal bridle revisited: an improvement in the technique to prevent unintentional removal of small-bore nasoenteric feeding tubes.

Critical care medicine·1996
Same author

Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock.

Infection and immunity·1996
Same journal

Palliative care in the intensive care unit.

New horizons (Baltimore, Md.)·2001
Same journal

An international perspective on the treatment of pediatric shock: the Brazilian experience.

New horizons (Baltimore, Md.)·1998
Same journal

Nutrition and shock in pediatric patients.

New horizons (Baltimore, Md.)·1998
Same journal

Recent advances in pediatric cardiopulmonary resuscitation and advanced life support.

New horizons (Baltimore, Md.)·1998
Same journal

Potential protective role of the heat shock response in sepsis.

New horizons (Baltimore, Md.)·1998
Same journal

Molecular biology of septic shock.

New horizons (Baltimore, Md.)·1998
See all related articles

Endotoxin, a component of Gram-negative bacteria, triggers inflammation in septic shock. Despite therapies targeting endotoxin, outcomes in severe sepsis remain poor, suggesting challenges in efficacy or approach.

Area of Science:

  • Microbiology
  • Immunology
  • Pathophysiology

Background:

  • Endotoxin (lipopolysaccharide) is a key component of Gram-negative bacterial cell walls.
  • It triggers a host inflammatory response crucial for fighting infection but can also cause organ dysfunction and death in septic shock.

Purpose of the Study:

  • To review the historical understanding of endotoxin's role in human septic shock.
  • To examine the development and outcomes of anti-endotoxin therapies.

Main Methods:

  • Historical review of scientific literature.
  • Analysis of clinical trial data regarding anti-endotoxin therapies.

Main Results:

  • Anti-endotoxin therapies have not significantly improved outcomes in severe sepsis.

Related Experiment Videos

  • Potential reasons include lack of compound efficacy or flawed investigative strategies.

    • Conclusions:

    • Understanding endotoxin's complex role in septic shock pathophysiology is evolving.
    • Further research is needed to develop effective anti-endotoxin strategies or refine therapeutic approaches.